Home    About Us    Medic-All    Bio B2B    Hot Topic     Expo     Login | Join Now          
Bio B2BTaiRx, Inc. 〉Rexis®

Rexis®

Rexis®

Rexis® is being developed as an add-on injection therapy for patients with sepsis.

Request for Collaboration
Overview
Rexis® is being developed as an add-on injection therapy for patients with sepsis. Several studies have demonstrated a reduction in mortality rate with the addition of Rexis® compared to the standard treatment. Rexis® will soon initiate pivotal clinical trials follow by regulatory registrations in 2016. We hope to increase the survival rate of sepsis and bring hope to patients diagnosed with this devastating disease with Rexis®.
Application
Sepsis
Collaboration Options
We wish to seek co-development opportunities in Asia.
People who like this also like
  • FB825FB825
  • TLC388TLC388
  • GLP LaboratoriesGLP Laboratories
  • Implant SystemImplant System
  • Taigexyn®  (Nemonoxacin)Taigexyn® (Nemonoxacin)
  • Carrier screening for fragile X syndromeCarrier screening for fragile X syndrome
  • Analysis Method for Breast Image and Electronic Apparatus ThereofAnalysis Method for Breast Image and Electronic Apparatus Thereof
  • Chemistry Manufacturing and Controls (CMC)Chemistry Manufacturing and Controls (CMC)
  • Multiple-Phasic Release Technology (MPRT)Multiple-Phasic Release Technology (MPRT)
  • TAT-HOXB4TAT-HOXB4